Diagnostic options · UAE

Histology tests in Dubai & UAE

Compare available Histology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

107

Listed price range

450.00–15,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Histology test prices

Showing 31–45 of 107 matching tests.

Histology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2045 IDH1 Mutation Immunohistochemistry Test This test detects the presence of the IDH1 R132H mutant protein in formalin-fixed paraffin-embedded (FFPE) tumor tissue.	Archival Tissue Specimen – FFPE tumor block or formalin-fixed biopsy slides	5 days (standard FFPE block) / 7 days (large or complex specimens)	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IDH1 R132H mutant protein"] Parameters [] Preparation ["Submit FFPE block or formalin-fixed biopsy with histopathology report, biopsy site, and clinical history."] Indications ["Suspected or confirmed glioma", "Need for glioma classification", "Prognostic assessment", "Therapeutic stratification"] Measurement technique Confirm with laboratory Codes LOINC: 94477-8 ICD-10: C71.9, C71.0, C71.1 Clinical summary This test detects the presence of the IDH1 R132H mutant protein in formalin-fixed paraffin-embedded (FFPE) tumor tissue.
TEST-2010 IgG4 Immunohistochemistry (IHC) Test This test identifies IgG4-positive plasma cells in tissue biopsies to aid in diagnosing IgG4-related disease.	Archival Tissue Specimen (FFPE Block or Biopsy Slides)	5–7 working days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IgG4-positive plasma cells", "Tissue distribution of IgG4"] Parameters [] Preparation ["Provide original histopathology report.", "Provide biopsy site details.", "Provide relevant clinical history."] Indications ["Diagnosis of IgG4-related disease", "Differentiation from other inflammatory or neoplastic conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21952-8 ICD-10: M35.0 Clinical summary This test identifies IgG4-positive plasma cells in tissue biopsies to aid in diagnosing IgG4-related disease.
TEST-1488 IHC Any Single Marker (HER2/neu, C4d, EBER, Ki‑67) Test This test detects the presence and intensity of a single target protein (HER2/neu, C4d, EBER, or Ki‑67) within formalin-fixed paraffin-embedded tissue sections.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Surgical Pathology Slides	3 business days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HER2/neu protein expression", "C4d deposition", "EBER RNA presence", "Ki‑67 proliferation index"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Diagnosis and prognosis of certain cancers (e.g., breast cancer)", "Evaluation of transplant rejection", "Diagnosis of EBV-associated disorders", "Tumour grading and proliferation assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21651-4 ICD-10: Z01.89 Clinical summary This test detects the presence and intensity of a single target protein (HER2/neu, C4d, EBER, or Ki‑67) within formalin-fixed paraffin-embedded tissue sections.
TEST-1478 IHC Extended Panel (>10 Markers) Test This diagnostic test evaluates multiple protein biomarkers in tumor tissue using immunohistochemistry to aid in cancer classification and treatment planning.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides (Archival Tissue Specimen)	5 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures [">10 protein markers", "Specific antigens in tumor tissue"] Parameters [] Preparation [] Indications ["Cancer subtyping", "Personalized therapeutic strategies", "Determining cancer type and behavior", "Suitability for targeted therapies"] Measurement technique Confirm with laboratory Codes LOINC: 47527-9 ICD-10: C80.1 Clinical summary This diagnostic test evaluates multiple protein biomarkers in tumor tissue using immunohistochemistry to aid in cancer classification and treatment planning.
TEST-2101 IHC TSH Test This diagnostic test evaluates the presence and expression level of Thyroid Stimulating Hormone (TSH) protein within tissue samples.	FFPE Tissue Block or Biopsy Slide	5–7 Business Days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Thyroid Stimulating Hormone (TSH) protein expression", "Tissue-specific TSH expression"] Parameters [] Preparation ["No special patient preparation is needed."] Indications ["Diagnosis of thyroid malignancies", "Subtyping of thyroid malignancies", "Guidance for therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 34707-6 ICD-10: C73 Clinical summary This diagnostic test evaluates the presence and expression level of Thyroid Stimulating Hormone (TSH) protein within tissue samples.
TEST-1477 Immunohistochemistry (IHC) Breast Cancer Prognostic Panel (ER, PR, HER2/neu, Ki‑67) Test This diagnostic test evaluates the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu), and the proliferation mark...	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slide	6 days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Estrogen Receptor (ER) expression", "Progesterone Receptor (PR) expression", "HER2/neu overexpression", "Ki‑67 proliferation index"] Parameters [{"name": "Estrogen Receptor (ER)", "reference_range": "Allred score 0-8 (0-2 negative, 3-8 positive)"}, {"name": "Progesterone Receptor (PR)", "reference_range": "Allred score 0-8 (0-2 negative, 3-8 positive)"}, {"name": "HER2/neu", "reference_range": "0, 1+ (negative), 2+ (equivocal), 3+ (positive)"}, {"name": "Ki‑67", "reference_range": "Percentage of positive tumour cells"}] Preparation ["A valid DHA-licensed doctor’s prescription is mandatory.", "Inform your doctor about any blood-thinning medications if a biopsy is required."] Indications ["Diagnosis and classification of breast cancer", "Guiding treatment decisions for breast cancer", "Prognosis assessment in breast cancer"] Measurement technique Confirm with laboratory Codes LOINC: 94548-3 ICD-10: C50.9 Clinical summary This diagnostic test evaluates the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/neu), and the proliferation marker Ki‑67 in breast cancer tissue.
TEST-1469 Immunohistochemistry (IHC) Panel Test This test evaluates protein expression patterns on cancer cells within FFPE tissue to aid in cancer subtyping and treatment selection.	Archival FFPE Tissue Block / Unstained Slides	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Specific protein antigens on cancer cells", "Protein expression patterns"] Parameters [] Preparation ["Ensure specimen is placed in 10% neutral buffered formalin immediately upon collection.", "Do not discontinue anticoagulants, immunosuppressants, or any prescribed medication without explicit instruction from your treating physician."] Indications ["Cancer subtyping", "Selection of targeted therapies", "Refining prognostic accuracy"] Measurement technique Confirm with laboratory Codes LOINC: 77599-8 ICD-10: C80.1, Z85.9 Clinical summary This test evaluates protein expression patterns on cancer cells within FFPE tissue to aid in cancer subtyping and treatment selection.
TEST-2071 Immunohistochemistry (IHC) Prostate Benign vs Malignant Panel Test This diagnostic assay distinguishes benign prostatic hyperplasia from malignant adenocarcinoma using multi-marker immunohistochemistry and DNA analysis.	Archival Tissue Specimen (FFPE Tissue Block or Biopsy Slides)	Block: 5 days; Complex tissue: 7 days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein markers (e.g., AMACR, basal cell markers)", "DNA fragment/STR analysis (Loss of heterozygosity, microsatellite instability)", "Morphological assessment (Hematoxylin & Eosin)"] Parameters [] Preparation ["No fasting required", "No medication changes required unless advised by urologist", "Provide histopathology report, biopsy site, and clinical history", "Sample required: FFPE tissue block or slides preserved in 10% formalin"] Indications ["Differential diagnosis of prostate lesions", "Confirmation of malignancy in biopsy specimens", "Assessment of high-grade prostatic intraepithelial neoplasia (PIN)", "Guiding targeted urological interventions"] Measurement technique Confirm with laboratory Codes LOINC: 57830-6 ICD-10: C61, D29.1, Z80.42 Clinical summary This diagnostic assay distinguishes benign prostatic hyperplasia from malignant adenocarcinoma using multi-marker immunohistochemistry and DNA analysis.
TEST-1803 Immunohistochemistry (IHC) Test This diagnostic test evaluates key protein biomarkers (ER, PR, HER2, Ki-67) in breast tumor tissue using digital image analysis.	FFPE tumor block or 10% formalin-fixed biopsy tissue	5–7 business days	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Estrogen Receptor (ER)", "Progesterone Receptor (PR)", "HER2 oncoprotein", "Ki-67 proliferation marker"] Parameters [{"name": "Estrogen Receptor (ER)", "reference_range": "0–3+ score"}, {"name": "Progesterone Receptor (PR)", "reference_range": "0–3+ score"}, {"name": "HER2 oncoprotein", "reference_range": "0–3+ score"}, {"name": "Ki-67 proliferation marker", "reference_range": "Quantifiable percentage"}] Preparation ["Submit formalin-fixed paraffin-embedded (FFPE) tumor block or 10% neutral buffered formalin-fixed biopsy tissue.", "Accompany sample with a copy of the histopathology report and clinical history."] Indications ["Diagnosis of breast cancer", "Treatment planning for breast cancer", "Prognosis assessment in breast cancer"] Measurement technique Confirm with laboratory Codes LOINC: 85319-2 ICD-10: C50.9 Clinical summary This diagnostic test evaluates key protein biomarkers (ER, PR, HER2, Ki-67) in breast tumor tissue using digital image analysis.
TEST-1942 Immunohistochemistry (Smooth Muscle Actin Test This test identifies the presence and distribution of smooth muscle actin protein within tissue samples, aiding in tumor classification and diagnosis.	Archival Tissue (formalin‑fixed paraffin‑embedded block or slides)	5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Smooth Muscle Actin (SMA) protein expression", "Myoepithelial cell differentiation"] Parameters [] Preparation ["No fasting or dietary restrictions required", "Provide original histopathology report, exact biopsy site, and complete clinical history", "Continue regular medications unless instructed otherwise by physician"] Indications ["Diagnosis and classification of sarcomas (e.g., leiomyosarcoma)", "Evaluation of breast and salivary gland carcinomas", "Assessment of uterine smooth muscle tumors of uncertain malignant potential (STUMP)"] Measurement technique Confirm with laboratory Codes LOINC: 34758-7 ICD-10: C49.9 Clinical summary This test identifies the presence and distribution of smooth muscle actin protein within tissue samples, aiding in tumor classification and diagnosis.
TEST-1913 Immunohistochemistry ACTH Test This test detects the presence and location of ACTH hormone within tissue samples, aiding in the diagnosis and classification of ACTH-secreting tumours.	Formalin-fixed paraffin-embedded (FFPE) tissue block	5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Adrenocorticotropic hormone (ACTH) expression", "Tissue-level protein localization"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Differentiation of pituitary adenomas", "Identification of ectopic ACTH sources", "Classification of neuroendocrine tumours"] Measurement technique Confirm with laboratory Codes LOINC: 21981-1 ICD-10: C75.1, E24.0 Clinical summary This test detects the presence and location of ACTH hormone within tissue samples, aiding in the diagnosis and classification of ACTH-secreting tumours.
TEST-1947 Immunohistochemistry Any 3 Markers Test This test identifies the presence and expression levels of three specific proteins within cancer tissue.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides – Archival Specimen	5–7 working days	950.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cancer protein expression", "Protein localization"] Parameters [] Preparation ["No fasting required", "No medication withdrawal needed unless instructed by physician"] Indications ["Cancer diagnosis", "Prognosis determination", "Therapeutic guidance"] Measurement technique Confirm with laboratory Codes LOINC: 16159-8 ICD-10: Z12.9 Clinical summary This test identifies the presence and expression levels of three specific proteins within cancer tissue.
TEST-1924 Immunohistochemistry Any 5 Markers (Without Interpretation) Test This diagnostic test evaluates the expression levels of five specified protein markers in formalin-fixed paraffin-embedded (FFPE) tumor tissue using automated immunohistochemistry.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Surgical Pathology Cuts	5 working days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Protein expression levels", "Staining intensity", "Percentage positivity"] Parameters [] Preparation ["No fasting required", "No specific medication or diet instructions"] Indications ["Tumor profiling", "Guiding targeted therapy", "Differential diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 69060-4 ICD-10: C80.1 Clinical summary This diagnostic test evaluates the expression levels of five specified protein markers in formalin-fixed paraffin-embedded (FFPE) tumor tissue using automated immunohistochemistry.
TEST-1955 Immunohistochemistry Arginase-1 Test This test identifies the presence of the Arginase-1 enzyme in tissue samples to help determine if a liver tumor is primary hepatocellular carcinoma (HCC).	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Tumor Tissue in 10% Neutral Buffered Formalin-Saline	5–7 Days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Arginase-1 enzyme expression", "Tissue-level antigen presence"] Parameters [] Preparation ["No patient preparation required", "No fasting required", "No medication adjustments needed"] Indications ["Differentiation of primary HCC from metastatic adenocarcinomas", "Evaluation of poorly differentiated HCC variants", "Confirmation of HCC origin in liver biopsies/resections"] Measurement technique Confirm with laboratory Codes LOINC: 50595-8 ICD-10: C22.0, C22.9, Z12.89 Clinical summary This test identifies the presence of the Arginase-1 enzyme in tissue samples to help determine if a liver tumor is primary hepatocellular carcinoma (HCC).
TEST-1825 Immunohistochemistry BCL-6 Test This test detects the presence and expression level of the BCL-6 protein in tumor tissue, aiding in the diagnosis and sub-classification of B-cell lymphomas.	Archival Tissue Specimen (FFPE Tissue Block or Tissue Sections in 10% Formal-Saline)	5–7 working days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCL-6 protein expression", "Germinal center B-cell lineage"] Parameters [] Preparation ["No specific patient preparation (e.g., fasting) is required as the tissue is already collected via biopsy."] Indications ["Diagnosis of Non-Hodgkin Lymphoma", "Sub-classification of Diffuse Large B-cell Lymphoma (DLBCL)", "Sub-classification of Follicular Lymphoma", "Prognostic stratification in lymphoma"] Measurement technique Confirm with laboratory Codes LOINC: 84900-9 ICD-10: C83.3, C82.9 Clinical summary This test detects the presence and expression level of the BCL-6 protein in tumor tissue, aiding in the diagnosis and sub-classification of B-cell lymphomas.

Category overview

Histology: overview

Gaining clarity at the microscopic level is a critical step in accurately identifying the root causes of underlying health concerns. At DNA Labs UAE, our Histology services provide meticulous tissue examinations using advanced staining techniques and high-resolution microscopy. This in-depth histological testing in the UAE equips your healthcare provider with the precise structural details necessary to guide their clinical decision-making and patient care. As one of the most respected diagnostic labs in Dubai/UAE, we are dedicated to providing fast, pinpoint-accurate turnaround times while safeguarding your sensitive health information with strict confidentiality. Move forward with confidence. Explore our histology diagnostic services, coordinate a sample collection with your physician, or contact our specialists for more information.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Histology tests in Dubai & UAE

Histology test prices

Histology: overview

Use the test details as a conversation starter

Related Histology categories